- mail us help@24marketresearch.com
- Int'l 1(332) 2424 294 (Int'l)
TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media
The Asia Pacific Pharmaceutical Grade Ethanol market size was valued at US$ 0.87 million in 2024 and is projected to reach US$ 1.16 billion by 2030, at a CAGR of 4.9% during the forecast period 2024-2030.
Pharmaceutical grade ethanol is high-purity alcohol used in the production of medicines, vaccines, and other pharmaceutical products, meeting stringent quality and regulatory standards for use in healthcare applications.
The Asia Pacific pharmaceutical grade ethanol market is experiencing steady growth, driven by the expanding pharmaceutical industry and increasing healthcare investments. China accounts for 40% of the market, followed by India at 30% and Japan at 20%. In 2023, the pharmaceutical manufacturing sector consumed 70% of total production, with antiseptics and disinfectants at 20% and vaccine production at 10%. The market saw a 15% increase in demand due to the COVID-19 pandemic and vaccine production efforts. Key players include Godavari Biorefineries Ltd. (India) and Greenfield Global Inc. (Canada), holding a combined 35% market share in the region. The industry is investing in advanced purification technologies, with a 10% increase in R&D spending on continuous distillation processes in 2023. Challenges include volatile raw material prices and strict regulatory compliance, leading to an 8% rise in production costs. The trend towards biopharmaceuticals has driven a 12% growth in ethanol demand for protein purification processes. The market is benefiting from the expansion of contract manufacturing organizations (CMOs) in the region, with a 20% increase in pharmaceutical grade ethanol consumption by CMOs for various drug formulations.
Report Includes
This report is an essential reference for who looks for detailed information on Asia Pacific Pharmaceutical Grade Ethanol . The report covers data on Asia Pacific markets including historical and future trends for supply, market size, prices, trading, competition and value chain as well as Asia Pacific major vendors¡¯ information. In addition to the data part, the report also provides overview of Pharmaceutical Grade Ethanol , including classification, application, manufacturing technology, industry chain analysis and latest market dynamics. Finally, a customization report in order to meet user's requirements is also available.
This report aims to provide a comprehensive presentation of the Asia Pacific Pharmaceutical Grade Ethanol , with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Grade Ethanol . This report contains market size and forecasts of Pharmaceutical Grade Ethanol in Asia Pacific, including the following market information:
We surveyed the Pharmaceutical Grade Ethanol manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
The report also provides analysis of leading market participants including:
• Key companies Pharmaceutical Grade Ethanol revenues in Asia Pacific market, 2019-2024 (Estimated), ($ millions)
• Key companies Pharmaceutical Grade Ethanol revenues share in Asia Pacific market, 2023 (%)
• Key companies Pharmaceutical Grade Ethanol sales in Asia Pacific market, 2019-2024 (Estimated),
• Key companies Pharmaceutical Grade Ethanol sales share in Asia Pacific market, 2023 (%)
Key Points of this Report:
• The depth industry chain includes analysis value chain analysis, porter five forces model analysis and cost structure analysis
• The report covers Asia Pacific and country-wise market of Pharmaceutical Grade Ethanol
• It describes present situation, historical background and future forecast
• Comprehensive data showing Pharmaceutical Grade Ethanol capacities, production, consumption, trade statistics, and prices in the recent years are provided
• The report indicates a wealth of information on Pharmaceutical Grade Ethanol manufacturers
• Pharmaceutical Grade Ethanol forecast for next five years, including market volumes and prices is also provided
• Raw Material Supply and Downstream Consumer Information is also included
• Any other user's requirements which is feasible for us
Reasons to Purchase this Report:
• Analyzing the outlook of the market with the recent trends and SWOT analysis
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and non-economic aspects
• Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
• Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
• Distribution Channel sales Analysis by Value
• Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
• Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
• 1-year analyst support, along with the data support in excel format.
1.1 Product Overview and Scope of Pharmaceutical Grade Ethanol
1.2.1 Asia Pacific Market Size YoY Growth Rate Analysis by Type: 2023 VS 2030
1.2.2 Low Purity
1.2.3 High Purity
1.3.1 Asia Pacific Market Size YoY Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Pharmaceutical and Medical
1.3.3 Personal Care & Cosmetic
1.4 Asia Pacific Market Growth Prospects
1.4.1 Asia Pacific Revenue Estimates and Forecasts (2019-2030)
1.4.2 Asia Pacific Production Estimates and Forecasts (2019-2030)
2.1 Industry Trends
2.1.1 SWOT Analysis
2.1.2 PESTEL Analysis
2.1.3 Porter’s Five Forces Analysis
2.2 Potential Market and Growth Potential Analysis
3.1 Asia Pacific Production by Manufacturers (2019-2023)
3.2 Asia Pacific Revenue Market Share by Manufacturers (2019-2023)
3.3 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Asia Pacific Average Price by Manufacturers (2019-2023)
3.5 Manufacturers Production Sites, Area Served, Product Type
3.6 Market Competitive Situation and Trends
3.6.1 Market Concentration Rate
3.6.2 Asia Pacific 5 and 10 Largest Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4.1 Asia Pacific Production
4.1.1 Asia Pacific Production YoY Growth Rate (2019-2023)
4.1.2 Asia Pacific Production, Revenue, Price and Gross Margin (2019-2024)
5.1 Asia Pacific
5.1.1 Asia Pacific Consumption by Country
5.1.2 Asia Pacific Sales, Consumption, Export, Import (2019-2023)
5.1.1 China
5.2.2 India
5.3.3 Japan
5.4.4 South Korea
5.5.5 Australia
5.6.6 Thailand
5.7.7 Indonesia
6.1 Asia Pacific Production Market Share by Type (2019-2024)
6.2 Asia Pacific Revenue Market Share by Type (2019-2024)
6.3 Asia Pacific Price by Type (2019-2024)
7.1 Asia Pacific Production Market Share by Application (2019-2024)
7.2 Asia Pacific Revenue Market Share by Application (2019-2024)
7.3 Asia Pacific Price by Application (2019-2024)
8.1 Zhejiang Huayi Pharmaceutical Co., Ltd.
8.1.1 Zhejiang Huayi Pharmaceutical Co., Ltd. Corporation Information
8.1.2 Zhejiang Huayi Pharmaceutical Co., Ltd. Product Portfolio
8.1.3 Zhejiang Huayi Pharmaceutical Co., Ltd. Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.1.4 Zhejiang Huayi Pharmaceutical Co., Ltd. Main Business and Markets Served
8.1.5 Zhejiang Huayi Pharmaceutical Co., Ltd. Recent Developments/Updates
8.2 Jiangsu Hengrui Medicine Co., Ltd.
8.2.1 Jiangsu Hengrui Medicine Co., Ltd. Corporation Information
8.2.2 Jiangsu Hengrui Medicine Co., Ltd. Product Portfolio
8.2.3 Jiangsu Hengrui Medicine Co., Ltd. Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.2.4 Jiangsu Hengrui Medicine Co., Ltd. Main Business and Markets Served
8.2.5 Jiangsu Hengrui Medicine Co., Ltd. Recent Developments/Updates
8.3 Shanghai Industrial United Holdings Co., Ltd.
8.3.1 Shanghai Industrial United Holdings Co., Ltd. Corporation Information
8.3.2 Shanghai Industrial United Holdings Co., Ltd. Product Portfolio
8.3.3 Shanghai Industrial United Holdings Co., Ltd. Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.3.4 Shanghai Industrial United Holdings Co., Ltd. Main Business and Markets Served
8.3.5 Shanghai Industrial United Holdings Co., Ltd. Recent Developments/Updates
8.4 Mitsubishi Chemical Corporation
8.4.1 Mitsubishi Chemical Corporation Corporation Information
8.4.2 Mitsubishi Chemical Corporation Product Portfolio
8.4.3 Mitsubishi Chemical Corporation Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.4.4 Mitsubishi Chemical Corporation Main Business and Markets Served
8.4.5 Mitsubishi Chemical Corporation Recent Developments/Updates
8.5 LG Chem Ltd.
8.5.1 LG Chem Ltd. Corporation Information
8.5.2 LG Chem Ltd. Product Portfolio
8.5.3 LG Chem Ltd. Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.5.4 LG Chem Ltd. Main Business and Markets Served
8.5.5 LG Chem Ltd. Recent Developments/Updates
8.6 Godavari Biorefineries Ltd.
8.6.1 Godavari Biorefineries Ltd. Corporation Information
8.6.2 Godavari Biorefineries Ltd. Product Portfolio
8.6.3 Godavari Biorefineries Ltd. Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.6.4 Godavari Biorefineries Ltd. Main Business and Markets Served
8.6.5 Godavari Biorefineries Ltd. Recent Developments/Updates
8.7 Jiangsu Lianhai Biological Technology Co., Ltd.
8.7.1 Jiangsu Lianhai Biological Technology Co., Ltd. Corporation Information
8.7.2 Jiangsu Lianhai Biological Technology Co., Ltd. Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.7.3 Jiangsu Lianhai Biological Technology Co., Ltd. Main Business and Markets Served
8.7.4 Jiangsu Lianhai Biological Technology Co., Ltd. Recent Developments/Updates
8.8 Indian Glycols Limited
8.8.1 Indian Glycols Limited Corporation Information
8.8.2 Indian Glycols Limited Product Portfolio
8.8.3 Indian Glycols Limited Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.8.4 Indian Glycols Limited Main Business and Markets Served
8.8.5 Indian Glycols Limited Recent Developments/Updates
8.9 Wilmar International Limited
8.9.1 Wilmar International Limited Corporation Information
8.9.2 Wilmar International Limited Product Portfolio
8.9.3 Wilmar International Limited Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.9.4 Wilmar International Limited Main Business and Markets Served
8.9.5 Wilmar International Limited Recent Developments/Updates
8.10 Piramal Pharma Solutions
8.10.1 Piramal Pharma Solutions Corporation Information
8.10.2 Piramal Pharma Solutions Product Portfolio
8.10.3 Piramal Pharma Solutions Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.10.4 Piramal Pharma Solutions Main Business and Markets Served
8.10.5 Piramal Pharma Solutions Recent Developments/Updates
9.1 Key Raw Materials Analysis
9.1.1 Key Raw Materials
9.1.2 Key Suppliers of Raw Materials
9.2 Proportion of Manufacturing Cost Structure
9.3 Manufacturing Process Analysis of Pharmaceutical Grade Ethanol
9.4 Industrial Chain Analysis
10.1 Marketing Channel
10.2 Distributors List
10.3 Customers
11.1 Industry Trends
11.2 Market Drivers
11.3 Market Challenges
11.4 Market Restraints
12.1 Asia Pacific Production, Revenue Forecast (2024-2030)
13.1 Asia Pacific Forecasted Consumption of by Country
14.1 Asia Pacific Production, Revenue and Price Forecast by Type (2024-2030)
14.1.1 Asia Pacific Forecasted Production of by Type (2024-2030)
14.1.2 Asia Pacific Forecasted Revenue of by Type (2024-2030)
14.1.3 Asia Pacific Forecasted Price of by Type (2024-2030)
14.2 Asia Pacific Production, Revenue and Price Forecast by Application (2024-2030)
14.2.1 Asia Pacific Forecasted Production of by Application (2024-2030)
14.2.2 Asia Pacific Forecasted Revenue of by Application (2024-2030)
14.2.3 Asia Pacific Forecasted Price of by Application (2024-2030)
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Author List
16.4 Disclaimer
17.1 Note
17.2 Examples of Clients
Frequently Asked Questions ?
